Oncopeptides AB (ONCO) — Financial Flexibility Index
Oncopeptides AB (ONCO) has a Financial Flexibility Index of -1.12x as of December 2025. Free cash flow of Skr-216.49 Million (operating CF Skr-216.49 Million minus capex Skr0.00) represents -1% of total liabilities (Skr193.73 Million). Also explore net asset momentum of Oncopeptides AB to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Oncopeptides AB Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for Oncopeptides AB across 12 annual periods. Check Oncopeptides AB (ONCO) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Oncopeptides AB (2014–2025)
Year-by-year free cash flow to debt coverage for Oncopeptides AB. For the full company profile including market capitalisation, see Oncopeptides AB stock valuation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.15x | Skr-222.88 Million | Skr-222.88 Million | Skr193.73 Million | ▲ +16.0% |
| 2024 | -1.37x | Skr-260.21 Million | Skr-260.57 Million | Skr189.91 Million | ▲ +10.9% |
| 2023 | -1.54x | Skr-279.38 Million | Skr-279.49 Million | Skr181.60 Million | ▲ +66.5% |
| 2022 | -4.59x | Skr-418.00 Million | Skr-420.51 Million | Skr91.03 Million | ▲ +30.8% |
| 2021 | -6.63x | Skr-1.52 Billion | Skr-1.52 Billion | Skr228.51 Million | ▼ -91.8% |
| 2020 | -3.46x | Skr-1.28 Billion | Skr-1.30 Billion | Skr369.86 Million | ▲ +1.2% |
| 2019 | -3.50x | Skr-687.94 Million | Skr-690.57 Million | Skr196.47 Million | ▼ -35.2% |
| 2018 | -2.59x | Skr-333.36 Million | Skr-333.73 Million | Skr128.70 Million | ▲ +40.7% |
| 2017 | -4.37x | Skr-270.02 Million | Skr-271.50 Million | Skr61.82 Million | ▼ -24.1% |
| 2016 | -3.52x | Skr-103.15 Million | Skr-104.26 Million | Skr29.30 Million | ▲ +52.3% |
| 2015 | -7.38x | Skr-51.69 Million | Skr-52.81 Million | Skr7.00 Million | ▼ -34.3% |
| 2014 | -5.50x | Skr-30.32 Million | Skr-31.44 Million | Skr5.52 Million | — |